Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
Ruxolitinib cream for nonsegmental vitiligo
Official title: Topical Ruxolitinib for the Treatment of Immune-related Vitiligo-like Depigmentation: A Prospective, Multicentre Study of a Topical JAK-inhibitor
Status: Closed to new participants
Description:
University of Zurich plans to enroll about 34 participants. Ruxolitinib cream blocks JAK1 and JAK2 signals that help sustain the immune attack on pigment-producing cells. It is intended to calm inflammation and help affected skin regain color. Ruxolitinib cream is sold as Opzelura and is already approved in the United States for nonsegmental vitiligo in people age 12 and older and for atopic dermatitis. The study is testing a particular population or treatment approach. Possible effects include application-site acne, itching or redness, headache, and infections. People age 18 and older may qualify. The study is underway but is no longer accepting new participants.
Start date: July 25, 2024
Completion date: August 31, 2026
Organizer: University of Zurich
Contact: See contacts and locations in the ClinicalTrials.gov record
Clinical Trial Alerts
Sign up and be the first to know about updates on this trial.
FAQOther Questions
- How long does it take to treat vitiligo?
Vitiligo, a condition characterized by the loss of skin pigment, can be unpredictable in both progression and treatment. The time it takes to treat vitiligo varies significantly...
- Белые пятна на теле? Витилиго?
Гид по Витилиго — ваш компас в лабиринте загадочной болезни и непростых решений. Здесь всё по-честному, по делу и на понятном языке. Вы найдёте здесь: Объяснения, что происходи...
- Is there a special diet for vitiligo?
Recent research highlights the potential of diet and nutrition in managing vitiligo, offering an alternative where traditional therapies may be lacking. However, the relationshi...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.